Viewing Study NCT00464295


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-02-25 @ 2:31 AM
Study NCT ID: NCT00464295
Status: COMPLETED
Last Update Posted: 2007-12-14
First Post: 2007-04-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
Sponsor: Aga Khan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module